Erasca Stock (NASDAQ:ERAS), Quotes and News Summary

Q: What sector and industry does Erasca (ERAS) operate in?

Erasca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Erasca Stock (NASDAQ: ERAS) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 805.156K
Day Range	- - -
52 Wk Range	1.510 - 3.375
Market Cap	$269.660M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	8.16%
Days to Cover	16.54

Recent News

RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

$1.7M Bet On Erasca? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed lower by around 70 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Erasca Inc

Sector

Health Care

Industry

Biotechnology

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, develop...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Erasca (ERAS) stock?

You can purchase shares of Erasca (NASDAQ: ERAS) through any online brokerage.

View our list of the best stock brokerages.

Who are Erasca's (ERAS) competitors?

Other companies in Erasca’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Opthea (NASDAQ:OPT) and RAPT Therapeutics (NASDAQ:RAPT).

What is the target price for Erasca (ERAS) stock?

The latest price target for Erasca (NASDAQ: ERAS) was reported by Goldman Sachs on Tuesday, April 2, 2024. The analyst firm set a price target for 7.00 expecting ERAS to rise to within 12 months (a possible 293.26% upside). 10 analyst firms have reported ratings in the last year.

Current Stock Price for Erasca (ERAS)?

The stock price for Erasca (NASDAQ: ERAS) is $1.78 last updated April 18, 2024 at 6:47 PM EDT.

Does Erasca (ERAS) pay a dividend?

There are no upcoming dividends for Erasca.

When is Erasca (NASDAQ:ERAS) reporting earnings?

Erasca’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Erasca (ERAS) going to split?

There is no upcoming split for Erasca.

What sector and industry does Erasca (ERAS) operate in?

Erasca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-